Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Spectrum Science
Spectrum Science Appoints Lisa Talbot to Lead Communications Business
May 22, 2026
Apnimed Secures Up to $150 Million in Debt Financing with HealthCare Royalty Partners to Support Planned AD109 Commercial Launch
May 20, 2026
Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109
May 18, 2026
Spectrum Science Unifies Portfolio Companies Under Single Brand, Reinforcing Power of Integrated Strategic Platform
December 10, 2025
Spectrum Science introduces “Mo”, a Proprietary, AI-powered Digital Teammate Designed to Support All Client Teams
November 14, 2025
Apnimed Announces Publication in The Lancet of Positive Phase 2 Results Demonstrating Sulthiame’s Efficacy in Obstructive Sleep Apnea
November 5, 2025
Apnimed To Present Additional Phase 3 Data for AD109, an Investigational Oral Pill for Obstructive Sleep Apnea, at CHEST 2025 Annual Meeting
October 17, 2025